Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

iShares Genomics Immunology and Healthcare ETF (IDNA) Institutional Ownership

iShares Genomics Immunology and Healthcare ETF logo
$29.45 0.00 (0.00%)
As of 05/22/2026 04:10 PM Eastern
Compare

Institutional Ownership Changes (13F Filings) for iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$3.25M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$432.89K
Get IDNA Insider Trade Alerts

Want to know when executives and insiders are buying or selling iShares Genomics Immunology and Healthcare ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

IDNA Institutional Buying and Selling by Quarter

iShares Genomics Immunology and Healthcare ETF Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/23/2025 Triumph Capital Management1,481$35K0.0%N/A0.029%
11/17/2025 Triumph Capital Management1,481$35K0.0%N/A0.029%
11/17/2025 Flow Traders U.S. LLC27,716$655K0.0%-39.0%0.549%
11/17/2025 Ameriprise Financial Inc.71,473$1.69M0.0%+8.4%1.415%
11/10/2025 Portland Global Advisors LLC103,007$2.43M0.3%+0.7%2.040%
8/15/2025 Ameriprise Financial Inc.65,933$1.35M0.0%-1.1%1.280%
8/13/2025 Flow Traders U.S. LLC45,404$931K0.0%N/A0.882%
8/13/2025 Portland Global Advisors LLC102,323$2.10M0.2%N/A1.987%
4/22/2025Cambridge Investment Research Advisors Inc.19,797$406K0.0%+4.0%0.374%
2/17/2025Ameriprise Financial Inc.71,832$1.63M0.0%+23.6%1.228%
Goldman Sachs just told you what to buy (most people missed it) (Ad)

Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.tc pixel

See the stock positioned to solve AI's biggest power crisis
1/17/2025Avior Wealth Management LLC26,650$603K0.0%+180.5%0.456%
11/8/2024Avior Wealth Management LLC9,500$234K0.0%N/A0.162%
2/5/2024RiverFront Investment Group LLC38,919$896K0.0%-5.2%0.643%
11/15/2023Integrated Wealth Concepts LLC56,879$1.16M0.0%-14.7%0.940%
11/7/2023RiverFront Investment Group LLC41,046$835K0.0%-3.3%0.678%
8/1/2023RiverFront Investment Group LLC42,454$991K0.0%-2.7%0.696%
7/13/2023Cambridge Investment Research Advisors Inc.32,104$750K0.0%+6.5%0.526%
5/3/2023Integrated Wealth Concepts LLC10,876$253K0.0%N/A0.175%
4/28/2023Janney Montgomery Scott LLC39,360$916K0.0%-3.4%0.635%
3/6/2023OLD Mission Capital LLC5,298$133K0.0%N/A0.086%
2/24/2023RiverFront Investment Group LLC45,602$1.15M0.3%+96.0%0.741%
2/13/2023Wealthcare Advisory Partners LLC217,907$5.49M0.3%+23.9%3.543%
2/8/2023Cambridge Investment Research Advisors Inc.29,579$745K0.0%+2.2%0.481%
2/1/2023Janney Montgomery Scott LLC40,741$1.03M0.0%N/A0.662%
1/31/2023Westside Investment Management Inc.350$2.51M0.0%-66.7%0.006%
1/26/2023Vigilant Capital Management LLC1,000$25K0.0%N/A0.016%
1/25/2023Mayflower Financial Advisors LLC21,752$547K0.1%-6.9%0.354%
11/15/2022Flow Traders U.S. LLC11,470$303K0.0%N/A0.178%
11/9/2022Westside Investment Management Inc.1,050$21.21M0.1%+200.0%0.016%
10/17/2022Cambridge Investment Research Advisors Inc.28,952$764K0.0%-11.5%0.449%
8/8/2022Baird Financial Group Inc.33,338$963K0.0%-19.4%0.529%
8/2/2022Triumph Capital Management18,382$160K0.1%N/A0.292%
7/13/2022Cambridge Investment Research Advisors Inc.32,731$946K0.0%+55.4%0.515%
5/5/2022RiverFront Investment Group LLC24,394$840K0.0%+90.0%0.372%
4/21/2022Mayflower Financial Advisors LLC29,021$1M0.1%+32.6%0.427%
4/15/2022Wealthcare Advisory Partners LLC165,681$5.71M0.3%+26.6%2.436%
4/12/2022Wealthcare Capital Management LLC5,881$203K0.0%N/A0.086%


IDNA Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of iShares Genomics Immunology and Healthcare ETF shares: Portland Global Advisors LLC ($2.43M), Ameriprise Financial Inc. ($1.69M), Flow Traders U.S. LLC ($655K), Avior Wealth Management LLC ($603K), and Cambridge Investment Research Advisors Inc. ($406K), Triumph Capital Management ($35K).Learn more on iShares Genomics Immunology and Healthcare ETF's institutional investors.

The following institutional investors have purchased iShares Genomics Immunology and Healthcare ETF's stock in the last 24 months: Portland Global Advisors LLC ($103.01K), Flow Traders U.S. LLC ($45.40K), Avior Wealth Management LLC ($26.65K), Ameriprise Financial Inc. ($19.26K), Triumph Capital Management ($2.96K), and Cambridge Investment Research Advisors Inc. ($756.00).

Institutional investors have bought a total of 156,913 shares in the last 24 months. This purchase volume represents approximately $3.25M in transactions.

The following institutional investors have sold iShares Genomics Immunology and Healthcare ETF stock in the last 24 months: Flow Traders U.S. LLC ($17.69K), and Ameriprise Financial Inc. ($745.00).

Institutional investors have sold a total of 18,433 shares in the last 24 months. This volume of shares sold represents approximately $432.89K in transactions.


Related Companies

This page (NYSEARCA:IDNA) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel